Why the study?
Drug development and disease prevention of HF and AF are impeded by a lack of robust early-stage surrogates.
Do specific cardiac MRI measurements act as causal surrogate endpoints for the development of heart failure or atrial fibrillation?
Observational (n=36,548)
Do specific cardiac MRI measurements act as causal surrogate endpoints for the development of heart failure or atrial fibrillation?
Specific CMR measurements, such as biventricular ejection fraction and end-systolic volume, may serve as robust early-stage surrogate endpoints for the development of heart failure and atrial fibrillation.
Answers are grounded in this paper and cite their sources.
May support LV mass and stroke volume as causal surrogates for DCM and HF; leaves open prospective validation before clinical adoption.
BACKGROUND: Drug development and disease prevention of heart failure (HF) and atrial fibrillation (AF) are impeded by a lack of robust early-stage surrogates. We determined to what extent cardiac magnetic resonance (CMR) measurements act as surrogates for the development of HF or AF. METHODS: Genetic data were sourced on the association with 21 atrial and ventricular CMR measurements. Mendelian randomization was used to determine CMR associations with AF, HF, non-ischaemic cardiomyopathy (NICM), and dilated cardiomyopathy (DCM), noting that the definition of NICM includes DCM as a subset. Additionally, for the CMR surrogates of AF and HF, we explored their association with non-cardiac traits potentially influenced by cardiac disease liability. RESULTS: In total we find that 7 CMR measures (biventricular ejection fraction (EF) and end-systolic volume (ESV), as well as LV systolic volume (SV), end-diastolic volume (EDV), and mass to volume ratio (MVR)) associate with the development of HF, 5 with the development of NICM (biventricular EDV and ESV, LV-EF), 7 with DCM (biventricular EF, ESV, EDV, and LV end-diastolic mass (EDM), and 3 associate with AF (LV-ESV, RV-EF, RV-ESV). Higher EF of both ventricles associate with lower risk of HF and DCM, with biventricular ESV associating with all four cardiac outcomes. Higher values of biventricular EDV associate with lower risk of HF, and DCM. Exploring the associations of these CMR cardiac disease surrogates with non-cardiac traits confirms a strong link with diastolic blood pressure, as well as more specific associations with lung function (LV-ESV), HbA1c (LV-EDM), and type 2 diabetes (LV-SV). CONCLUSIONS: The current paper identifies key CMR measurements that may act as surrogate endpoints for the development of HF (including NICM and DCM) or AF.
No takes yet. Share an insight, caveat, or question.
Schmidt et al. (2025) conducted an observational in Heart failure and atrial fibrillation (n=36,548). Genetically predicted cardiac magnetic resonance (CMR) measurements was evaluated on Dilated cardiomyopathy (DCM) (OR 3.93, 95% CI 1.43-10.83).
Synapse has enriched 10 related papers. Consider them for comparative context: